Apr 14, 2011 by Xconomy .comAcorda Stock Halted as Shares Skyrocket on Patent SpeculationRBC Capital Markets are suggesting good things for the company's MS drug.
Apr 13, 2011 by Xconomy .comFord, Chasing Nissan and Chevy, Rolling Out Focus EVFord intends to differentiate itself from the rest of the EV crowd in a couple of ways.
Apr 9, 2011 by Xconomy .comGoogle and ITA Software: The Acquisition That Almost Wasn't, Is AgainWith some strings attached.
Apr 9, 2011 by Xconomy .comEvolve or Die: 4 Ways Med-Device Companies Can SurviveVersant's Beckie Robertson speaks her mind.
Apr 8, 2011 by Xconomy .comHow to Hire and Fire, Establish Company Culture, and Go Public: 10 Lessons from 3 Big CEOsTen quotable quotes from top CEOs.
Apr 5, 2011 by Xconomy .comAs Google Retools Its Search Engine, Content Farms Lose TractionGoogle is trying to improve the quality of the results it delivers to Web searchers.
Apr 2, 2011 by Xconomy .comDendreon Faces Internet-Fueled Shareholder UprisingAnd it's led by a little guy in Kansas.
Mar 25, 2011 by Xconomy .com"Consumer Surplus" from Personal Technology Is Soaring in the Age of AppreciationIs your iPhone -- and your iPad increasing in value?
Mar 21, 2011 by Xconomy .comT-Mobile's Sale to AT&T: What They're Saying, What It MeansWhat the deal means for the headquarters of the U.S. wireless business.
Mar 3, 2011 by Xconomy .comWith Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their NicheThe field might benefit from the increased interest in it among pharmaceutical players.
Feb 22, 2011 by Xconomy .comGilead Buys Calistoga Pharma, Making Move Into Cancer DrugsGilead diversifies with Calistoga purchase.
Feb 22, 2011 by Xconomy .comForest Labs Snaps Up Clinical DataThis deal is the latest proof that drug developers with FDA-approved treatments remain hot buyout targets in a pharma industry that is starved for new products to replace brand-name drugs.
Feb 9, 2011 by Xconomy .comAmgen Pushes Ahead With "Son of Dmab" for Treating BonesIs there more to Amgen than "Dmab"?
Feb 3, 2011 by Xconomy .comBoston Scientific Wants to Be a Rock Star. But First, It Needs Some StarsBoston Scientific has been talking the talk of late. But its walk the past few years can be best described as a limp.
Jan 28, 2011 by Xconomy .comMerck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, BiosimilarsBiotech drugs will soon dominate the pharmaceutical industry, and Merck is playing catch-up.
Jan 21, 2011 by Xconomy .comSearching for Meaning in Google's Leadership ChangesA range of reactions to Google's annoucement of leadership changes.
Jan 21, 2011 by Xconomy .comThe Age of Tablet Superbooks? Not YetThis tech analyst is underwhelmed by current tablet and e-reader options.
Jan 7, 2011 by Xconomy .comThe iPad and Rich Media Apps -- Capitalizing on the Future of StorytellingThe iPad's story of profit.
Jan 7, 2011 by Xconomy .comHere Are 6 Features Apple Should Include in the iPad 2Hey, Apple, listen up!
